pharma · Osteopenia · Heat Stress · PTPI
Petros Pharmaceuticals
Petros Pharmaceuticals patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
New York, USA HQ
3 Employees
Public company Type
PTPI · NYSE Ticker
Company details
- Status
- Public
- HQ
- New York, USA
- Employees
- 3
- Programs
- 3
- Drugs
- 3
- Patents
- 0
Petros Pharmaceuticals patents
0 pharmaceutical patents indexed for Petros Pharmaceuticals. 0 expire within 24 months.
Petros Pharmaceuticals has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Petros Pharmaceuticals have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Petros Pharmaceuticals patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.